We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Sugar Found in Red Meat Causes Chronic Inflammation in Human-Like Mouse Model

By LabMedica International staff writers
Posted on 06 Jan 2015
Chronic inflammation in humans, which has been linked to tumor formation as well as development of other syndromes such as atherosclerosis and type II diabetes, may be a response to red meat in the diet that contains the sugar N-Glycolylneuraminic acid (Neu5Gc).

Humans differ from other mammals by being unable to synthesize Neu5Gc, as the human CMAH gene has been irreversibly mutated and produces an inactive form of the enzyme CMP-N-acetylneuraminic acid hydroxylase, which is the enzyme responsible for synthesizing CMP-Neu5Gc from CMP-N-acetylneuraminic (CMP-Neu5Ac) acid. More...
Even though Neu5Gc cannot be produced by humans, it has been found in human cancers and fetal samples, which suggests that molecules of Neu5Gc enter human pathways through external sources, such as diet. Some researchers have suggested that eating red meat could lead to inflammation if the body’s immune system constantly generates antibodies against consumed animal Neu5Gc, a foreign molecule.

To study the relationship between red meat consumption and tumor development, investigators at the University of California, San Diego (USA) genetically engineered a mouse model to mimic the human condition by lacking Neu5Gc.

The investigators first evaluated the Neu5Gc content of various foods and showed that red meats were particularly rich in orally bioavailable Neu5Gc. They then fed this form of Neu5Gc to the human-like Neu5Gc-deficient mice. Results published in the December 29, 2014, online edition of the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS) revealed that when such mice were challenged with anti-Neu5Gc antibodies, they developed evidence of systemic inflammation. Long-term exposure to this combination resulted in a significantly higher incidence of carcinomas (five-fold increase) and an association with Neu5Gc accumulation in the tumors.

“Until now, all of our evidence linking Neu5Gc to cancer was circumstantial or indirectly predicted from somewhat artificial experimental setups,” said senior investigator Dr. Ajit Varki, professor of medicine and cellular and molecular medicine at the University of California, San Diego. “This is the first time we have directly shown that mimicking the exact situation in humans — feeding non-human Neu5Gc and inducing anti-Neu5Gc antibodies — increases spontaneous cancers in mice.”

“The final proof in humans will be much harder to come by,” said Dr. Varki. “But on a more general note, this work may also help explain potential connections of red meat consumption to other diseases exacerbated by chronic inflammation, such as atherosclerosis and type II diabetes. Of course, moderate amounts of red meat can be a source of good nutrition for young people. We hope that our work will eventually lead the way to practical solutions for this catch-22.”

Related Links:

University of California, San Diego



Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Collection and Transport System
PurSafe Plus®
New
Gold Member
Collection and Transport System
PurSafe Plus®
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Pathology

view channel
Image: The new system allows surgeons to identify genotyping of brain tumors and determine optimal resection margins during surgery (Photo courtesy of Nagoya University)

New Technique Detects Genetic Mutations in Brain Tumors During Surgery within 25 Minutes

Determining the genetic profile of brain tumors during surgery is crucial for improving patient outcomes, but conventional analysis methods can take up to two days, delaying critical decisions.... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.